Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Limb Lengthening After Distal Femoral Physeal Fractures

Ja
Jauniškytė E, Žulpaitė G, Laba...
January 01, 2026
0 views
View on PubMed
6 min read 1,196 words distal femoral physeal fractures Medically Reviewed

Overview

Limb lengthening is a concern for patients who have experienced distal femoral physeal fractures, especially in young children. These fractures can lead to growth arrest and limb-length discrepancy. According to a study published on PubMed, the risk of premature physeal closure is high in displaced high-energy distal femoral physeal injuries in younger children (Source: PubMed). This study highlights the importance of long-term follow-up and growth prediction in managing these injuries.

The study examined the case of a 6-year-old child who sustained an open distal femoral physeal fracture in an electric scooter-motor vehicle collision. The child underwent emergency treatment, including open reduction and crossed smooth Kirschner-wire fixation. Despite timely surgical treatment, the child developed progressive limb-length discrepancy, which increased over time.

What This Study Examined

The study focused on the management and long-term outcome of an open distal femoral physeal fracture in a young child. It examined the use of growth prediction using the multiplier method to estimate the final limb-length discrepancy at skeletal maturity.

Why This Matters for Patients

This study matters for patients who have experienced distal femoral physeal fractures, particularly in young children. It highlights the importance of long-term follow-up and growth prediction in managing these injuries and minimizing the risk of limb-length discrepancy. Patients who have experienced these fractures should be aware of the potential risks and complications, including growth arrest and the need for limb lengthening or epiphysiodesis.

Medical Background

Limb lengthening is a surgical procedure used to treat limb-length discrepancy. It involves the use of external fixators, intramedullary nails, or other devices to lengthen the bone. The procedure can be used to treat a variety of conditions, including physeal fractures, bone deformities, and bone defects.

How the Procedure Works

The limb lengthening procedure typically involves several steps. First, the surgeon will assess the patient's condition and determine the best course of treatment. This may involve the use of X-rays or other imaging tests to evaluate the bone. Next, the surgeon will perform the surgical procedure, which may involve the insertion of an external fixator or intramedullary nail. After the procedure, the patient will undergo a period of distraction osteogenesis, during which the bone is gradually lengthened using the external or internal device.

Who Is a Candidate?

Candidates for limb lengthening typically include patients who have experienced physeal fractures, bone deformities, or bone defects. These patients may have limb-length discrepancy or other conditions that affect the length or alignment of the bone. The procedure is typically performed on patients who are skeletally immature, meaning that their bones are still growing.

Clinical Summary

  • Procedure: Limb lengthening using external or internal devices
  • Typical Duration: Several months to several years, depending on the individual case
  • Recovery: Variable, depending on the individual case and the complexity of the procedure
  • Success Rate (general): High, with most patients achieving significant improvement in limb length and function

Study Methodology

The study was a case report that examined the management and long-term outcome of an open distal femoral physeal fracture in a 6-year-old child. The patient population consisted of a single patient who had sustained an open distal femoral physeal fracture in an electric scooter-motor vehicle collision. The follow-up duration was 5 years, during which the patient underwent regular assessments and treatments to manage the injury.

Patient Selection Criteria

The patient selection criteria for this study were based on the presence of an open distal femoral physeal fracture in a young child. The patient was selected for the study because of the rarity of this type of injury and the potential for long-term complications, including growth arrest and limb-length discrepancy.

Outcome Measures

The outcome measures for this study included the assessment of limb-length discrepancy and the evaluation of the patient's overall functional outcome. The study also examined the use of growth prediction using the multiplier method to estimate the final limb-length discrepancy at skeletal maturity.

Results & Findings

The study found that the patient developed progressive limb-length discrepancy over time, despite timely surgical treatment. The limb-length discrepancy increased from 1.3 cm at 10 months to 6.5 cm over 5 years. The study also found that growth prediction using the multiplier method was effective in estimating the final limb-length discrepancy at skeletal maturity.

Key Outcomes

The key outcomes of this study included the development of progressive limb-length discrepancy and the effectiveness of growth prediction using the multiplier method. The study also highlighted the importance of long-term follow-up and growth prediction in managing distal femoral physeal fractures in young children.

Complications & Risks

The study reported several complications and risks associated with distal femoral physeal fractures, including growth arrest and limb-length discrepancy. The study also reported the risk of epiphysiodesis to minimize the limb-length discrepancy.

Key Takeaways for Patients

Patients who have experienced distal femoral physeal fractures should be aware of the potential risks and complications, including growth arrest and limb-length discrepancy. Patients should also be aware of the importance of long-term follow-up and growth prediction in managing these injuries. Some key takeaways for patients include:

  • Understand the potential risks and complications associated with distal femoral physeal fractures
  • Be aware of the importance of long-term follow-up and growth prediction in managing these injuries
  • Ask their surgeon about the use of growth prediction and limb lengthening or epiphysiodesis to minimize limb-length discrepancy

Frequently Asked Questions

What is a distal femoral physeal fracture?
A distal femoral physeal fracture is a break in the growth plate at the end of the femur (thigh bone) that can affect the growth and development of the bone. It is a rare but potentially serious injury that requires timely and effective treatment to minimize the risk of long-term complications.
What are the potential complications of a distal femoral physeal fracture?
The potential complications of a distal femoral physeal fracture include growth arrest and limb-length discrepancy. These complications can have a significant impact on the patient's quality of life and may require additional surgical or non-surgical treatments to manage.
How is limb lengthening performed?
Limb lengthening is a surgical procedure that involves the use of external fixators or intramedullary nails to lengthen the bone. The procedure typically involves several steps, including the insertion of the external or internal device, followed by a period of distraction osteogenesis to gradually lengthen the bone.
What is growth prediction and how is it used in the management of distal femoral physeal fractures?
Growth prediction is a method of predicting the future growth and development of the bone based on the current age and size of the child. It is used in the management of distal femoral physeal fractures to estimate the final limb-length discrepancy at skeletal maturity and to guide the use of limb lengthening or epiphysiodesis to minimize the limb-length discrepancy.
What is the success rate of limb lengthening for distal femoral physeal fractures?
The success rate of limb lengthening for distal femoral physeal fractures is generally high, with most patients achieving significant improvement in limb length and function. However, the success rate can vary depending on the individual case and the complexity of the procedure.
More on: distal femoral physeal fractures Last reviewed: July 28, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Subject-Level Classification of Osteonecrosis of the Femoral Head Using Wearable IMU Gait Data: Expanded Review

Overview Osteonecrosis of the femoral head (ONFH) is a painful condition that can lead to collapse of the hip joint and early arthritis. While magnetic resonance imaging (MRI) and X‑ray remain the gold standard for diagnosing ONFH, they do not tell us how the disease affects everyday activities such as walking. A recent study explored whether data captured from wearable inertial measurement units (IMUs) during normal gait could reliably distinguish patients with ONFH from healthy individuals. Using advanced machine‑learning techniques, researchers achieved a classification accuracy of 94 percent, indicating that a simple walking test with a small sensor could become an objective tool for monitoring functional impairment. This matters for anyone with early‑stage hip disease, orthopaedic surgeons evaluating treatment response, and clinicians seeking non‑invasive, repeatable outcome measures. What This Study Examined The investigators recruited 21 adults with imaging‑confirmed ONFH and 30 age‑matched healthy volunteers. Each participant performed a self‑paced walk while bilateral foot‑mounted IMUs recorded three‑dimensional acceleration and angular velocity at 100 Hz. The raw signals were transformed into three feature sets—kinematic waveforms, scalar gait metrics, and dynamic asymmetry profiles—and fed into a hybrid deep‑learning model (CNN–CBAM–BiLSTM, MLP, and 1‑D ConvNet) that fused information at the feature level to produce a subject‑level classification. Why This Matters for Patients Current follow‑up for ONFH relies on periodic imaging, which can be costly, exposes patients to radiation (for CT), and may miss subtle functional changes. A wearable‑sensor approach offers a low‑cost, radiation‑free, and objective way to track how the disease impacts walking. If validated in larger cohorts, such technology could help clinicians decide when to intervene, personalize rehabilitation protocols, and potentially reduce the need for unnecessary imaging. Medical Background Osteonecrosis of the femoral head occurs when blood flow to the bone tissue inside the hip joint is disrupted, leading to cell death and eventual collapse of the subchondral bone. Common risk factors include corticosteroid use, alcohol abuse, traumatic injury, and certain blood‑clotting disorders. Early‑stage disease may be asymptomatic, but as the necrotic area expands, patients develop deep groin or knee pain that worsens with weight‑bearing activities. Diagnosis is typically made with MRI, which can detect necrotic lesions before they appear on plain radiographs. Staging systems (e.g., the Ficat‑Arlet classification) guide treatment decisions ranging from core decompression to total hip arthroplasty. However, these imaging tools do not quantify functional limitation, which is critical for determining the effectiveness of surgical or non‑surgical interventions. How the Procedure Works In the context of this research, the "procedure" refers to a wearable‑sensor gait assessment. Small, lightweight IMUs—each the size of a coin—are attached to the patient’s shoes or ankles. As the patient walks, the sensors capture acceleration and rotation data across three axes. Sophisticated algorithms then extract gait cycles, compute symmetry indices, and feed the information into a neural‑network model that classifies the presence or absence of ONFH. Who Is a Candidate? Any individual with a confirmed diagnosis of ONFH, particularly those in early or mid‑stage disease, could benefit from this type of functional assessment. It is also useful for healthy adults who serve as control subjects in research settings or for patients undergoing hip‑preserving surgeries (e.g., core decompression, osteotomy) who need objective tracking of functional recovery. Study Methodology Participant Recruitment 21 participants (mean age = 48 ± 9 years; 14 male, 7 female) with imaging‑confirmed ONFH, staged according to the Ficat‑Arlet system (12 in stage I, 9 in stage II). 30 healthy controls (mean age = 46 ± 8 years; 18 male, 12 female) matched on sex, age, and body‑mass index. Exclusion criteria included prior hip replacement, active lower‑limb injury within 6 months, or neurological disorders affecting gait. Instrumentation Two identical inertial measurement units (X‑Sense, 100 Hz sampling rate, 3‑axis accelerometer ± 16 g, 3‑axis gyroscope ± 2000 °/s) were securely affixed to the dorsal aspect of each foot using elastic Velcro straps. The sensors transmitted raw data to a laptop for real‑time logging. Calibration was performed before each session to ensure drift‑free measurements. Walking Protocol Participants walked at a self‑selected comfortable speed along a 10‑meter hallway, turning at each end, for a total of 2 minutes (approximately 120‑150 gait cycles per leg). No assistive devices were allowed. Foot‑contact events were identified using a threshold‑based algorithm on vertical acceleration, yielding precise heel‑strike timestamps. Feature Extraction Kinematic Waveforms: Each gait cycle was resampled to 120 points and concatenated across three axes of acceleration and three axes of angular velocity, creating a 17‑channel time series (including derived features such as jerk). Scalar Cycle‑Level Features: A 22‑dimensional vector captured traditional spatiotemporal metrics (step length, cadence, swing‑time variability), symmetry indices (e.g., symmetry angle), and frequency‑domain descriptors (power spectral density peaks). Dynamic Absolute Asymmetry Waveforms: For each cycle, the absolute difference between left‑ and right‑leg waveforms was computed, producing a 7‑channel asymmetry profile that emphasizes inter‑limb timing discrepancies. Model Architecture CNN–CBAM–BiLSTM Branch: The 17‑channel kinematic waveform entered a convolutional neural network (CNN) equipped with a Convolutional Block Attention Module (CBAM) to highlight salient temporal–spatial patterns, followed by a bidirectional long short‑term memory (BiLSTM) layer for sequence modelling. Multilayer Perceptron (MLP) Branch: The 22‑dimensional scalar vector was processed by a three‑layer MLP (128 → 64 → 32 neurons) with ReLU activation and dropout (0.3) for regularisation. 1‑D ConvNet Branch: The 7‑channel asymmetry waveform passed through a shallow 1‑dimensional convolutional network (kernel size = 3, stride = 1) to capture local asymmetry patterns. Feature vectors from the three branches were concatenated and fed into a final dense layer with sigmoid activation to generate a probability score for ONFH presence. Training and Validation Strategy Data were split using a 51‑fold leave‑one‑subject‑out cross‑validation (LOSO‑CV) scheme, ensuring that each participant served once as the test set while the remaining 50 participants formed the training set. All preprocessing (e.g., normalization, artifact removal) was performed exclusively on the training folds to avoid information leakage. Five random seeds (0‑4) were used to initialise network weights, producing five independent models whose outputs were averaged (ensemble) for the final prediction. Results & Findings Classification Performance MetricValue Accuracy0.9412 (94.1 %) Sensitivity (Recall)0.8571 (85.7 %) Specificity1.0000 (100 %) F1‑Score0.9231 (92.3 %) AUC‑ROC0.9556 (95.6 %) The ensemble achieved perfect specificity, meaning no healthy control was misclassified as having ONFH. Sensitivity, while slightly lower, still correctly identified the majority of diseased participants. Ablation Analysis When each feature branch was removed in turn, the scalar‑feature MLP branch contributed the greatest drop in performance (accuracy decreased to 0.8623). Removing the asymmetry branch reduced accuracy to 0.9047, indicating that asymmetry provided complementary but non‑essential information. The kinematic waveform branch alone yielded an accuracy of 0.8815, reinforcing the benefit of multimodal fusion. Confusion Matrix Predicted ONFH Healthy Actual ONFH 18 3 Actual Healthy 0 30 All 30 healthy subjects were correctly identified, while three ONFH participants were false‑negatives, primarily those in early stage I with minimal gait alteration. Statistical Validation A paired t‑test comparing the full model against each ablated version demonstrated statistically significant improvements (p 200 participants), longitudinal monitoring to assess disease progression, and integration with mobile‑app platforms for remote data capture. Researchers also aim to compare sensor‑derived metrics with patient‑reported outcome measures such as the Hip disability and Osteoarthritis Outcome Score (HOOS). Clinical Implications The study demonstrates that a brief, sensor‑based gait assessment can distinguish ONFH patients from healthy adults with high accuracy. If replicated in larger, heterogeneous cohorts, this technology could serve several practical roles: Early Detection: Subtle gait abnormalities preceding radiographic collapse could be flagged, prompting earlier imaging or therapeutic intervention. Monitoring Treatment Response: Clinicians could track functional improvement after core decompression, bisphosphonate therapy, or physical‑therapy regimens without exposing patients to repeated MRI. Personalised Rehabilitation: Quantitative asymmetry scores could guide targeted gait‑training programs, improving the efficiency of physiotherapy. Remote Follow‑up: Wearable sensors paired with a smartphone app could enable tele‑rehab visits, especially valuable for patients in rural settings. Cost Reduction: By decreasing the frequency of expensive imaging studies, healthcare systems may realise substantial savings while maintaining diagnostic vigilance. Importantly, the method is non‑invasive, repeatable, and does not rely on radiation, making it an attractive adjunct to current standard‑of‑care pathways. Frequently Asked Questions Q: Can this wearable sensor test replace MRI for diagnosing ONFH? A: No. The sensor provides functional information and can raise suspicion of disease, but imaging remains essential for confirming the diagnosis and staging the necrotic lesion. Q: How long does the gait assessment take? A: Participants walked for about two minutes, which yields roughly 120‑150 gait cycles per leg—sufficient data for the algorithm to generate a reliable classification. Q: Are there any risks associated with wearing the IMUs? A: The devices are lightweight, battery‑operated, and attach via soft straps, posing no known safety risk. They do not emit radiation or interfere with other medical equipment. Q: Will my insurance cover this test? A: At present, the technology is investigational and not yet reimbursed by most insurers. Coverage decisions will likely evolve as larger validation studies demonstrate clinical utility. Q: Could the system detect other hip‑related problems besides ONFH? A: The underlying gait‑analysis framework is adaptable. Ongoing research is exploring its application to osteoarthritis, femoroacetabular impingement, and post‑operative recovery after total hip arthroplasty. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Distal Interphalangeal Joint Enthesitis and Nail Psoriasis: Frequency, Association, and Clinical Implications

Overview Patients with psoriasis and psoriatic arthritis (PsA) often experience a spectrum of skin, nail, and musculoskeletal manifestations. Two of the most characteristic yet under‑appreciated features are nail psoriasis and enthesitis, particularly at the distal interphalangeal (DIP) joint. While skin plaques are the hallmark of psoriasis, nail changes occur in up to 50 % of patients and are strongly linked to PsA development and disease severity.1,2 Enthesitis, the inflammation where tendons, ligaments, or capsules attach to bone, is a core feature of spondyloarthropathies and contributes to pain, functional limitation, and structural damage. Recent research from a tertiary care hospital in Karachi examined how frequently DIP joint enthesitis occurs in patients with psoriasis (with or without PsA) and whether its presence is associated with nail psoriasis. The investigators used high‑resolution musculoskeletal ultrasound—a sensitive, non‑invasive imaging technique—to detect enthesitis that might otherwise be missed on clinical examination. Their findings revealed a statistically significant association, suggesting that nail involvement may serve as a clinical marker for underlying joint inflammation. Understanding this relationship is vital for clinicians, patients, and caregivers because it informs early screening strategies, risk stratification, and therapeutic decision‑making. Early identification of subclinical enthesitis could prompt more aggressive treatment, potentially preventing irreversible joint damage and improving quality of life. What This Study Examined The study investigated the link between nail psoriasis and DIP joint enthesitis in a cohort of 96 adults diagnosed with psoriasis, some of whom also met criteria for PsA. By correlating ultrasound‑verified enthesitis with clinical nail findings, the researchers aimed to quantify the frequency of DIP enthesitis and determine whether nail disease independently predicts its presence after adjusting for age, sex, disease duration, and PsA status. Why This Matters for Patients For patients, the practical takeaway is that nail changes are not merely cosmetic—they may signal deeper inflammation in the finger joints. This knowledge empowers patients to report nail abnormalities promptly, aiding clinicians in early detection of enthesitis and, by extension, early therapeutic intervention. Moreover, clinicians can incorporate routine ultrasound screening in patients with nail psoriasis to uncover occult DIP enthesitis before it manifests as pain or functional loss. Medical Background Psoriasis is a chronic, immune‑mediated disease that primarily affects the skin but can involve the joints, nails, and entheses. The disease is driven by dysregulated T‑cell activity, particularly Th17 and Th1 pathways, leading to keratinocyte hyperproliferation and systemic inflammation. Approximately 20‑30 % of individuals with psoriasis develop psoriatic arthritis, which can affect peripheral joints, the axial skeleton, and the entheses.3 Nail psoriasis manifests as pitting, onycholysis, subungual hyperkeratosis, and oil‑drop discoloration. These nail changes reflect involvement of the nail matrix and nail bed, structures that share embryologic origin with the distal interphalangeal joint capsule and surrounding enthesis. Consequently, nail psoriasis is often considered a clinical surrogate for DIP joint disease. Enthesitis is a hallmark of the spondyloarthropathy spectrum. In PsA, enthesitis most commonly involves the extensor tendons of the fingers and toes, the Achilles tendon, and the plantar fascia. The distal interphalangeal joint enthesis, located at the base of the nail, is especially prone to inflammation due to mechanical stress from daily activities and the shared vascular supply with the nail unit. How the Procedure Works While there is no single procedure that cures nail psoriasis or DIP enthesitis, a multimodal therapeutic approach is recommended. Topical treatments (e.g., high‑potency corticosteroids, vitamin D analogues) can improve superficial nail lesions. Systemic agents—such as methotrexate, leflunomide, or biologic therapies targeting tumor necrosis factor‑α (TNF‑α), interleukin‑17 (IL‑17), or interleukin‑23 (IL‑23)—address both skin and joint disease, including enthesitis. Musculoskeletal ultrasound, the imaging modality employed in the Karachi study, allows clinicians to visualize enthesopathic changes such as hypoechoic thickening, increased vascularity on Power Doppler, and erosions, thereby guiding treatment escalation. Study Methodology Design: Cross‑sectional analytical study conducted at the Department of Dermatology and Rheumatology, Civil Hospital Karachi, over a six‑month period after obtaining ethical approval. Sample Size and Selection: A total of 96 patients aged 18–65 years were recruited using non‑probability consecutive sampling. Inclusion criteria required a clinical diagnosis of psoriasis (with or without PsA) confirmed by a dermatologist and/or rheumatologist. Exclusion criteria included prior biologic therapy within three months, active infection, pregnancy, or co‑existing autoimmune conditions that could confound enthesitis assessment. Data Collection: Demographic data (age, sex), disease duration, presence of PsA (according to the Classification Criteria for Psoriatic Arthritis, CASPAR), and nail involvement (graded using the Nail Psoriasis Severity Index, NAPSI) were recorded. Each participant underwent bilateral high‑frequency (≥12 MHz) musculoskeletal ultrasound of the DIP joints of the index, middle, ring, and little fingers. Sonographers, blinded to the nail status, assessed for enthesitis based on the OMERACT definition (hypoechoic thickening, calcifications, erosions, and Power Doppler signal). Statistical Analysis: Data were entered into SPSS version 27.0. Categorical variables were expressed as frequencies and percentages; continuous variables as mean ± standard deviation. The association between nail psoriasis (present vs. absent) and DIP enthesitis (present vs. absent) was evaluated using Pearson’s chi‑square test or Fisher’s exact test where appropriate. A p‑value  15). Frequency of DIP Joint Enthesitis: Ultrasound‑confirmed DIP enthesitis was detected in 37.5 % of the total sample (n = 36). When stratified, 48 % of patients with nail psoriasis had enthesitis, compared with only 15 % of those without nail disease. Association Between Nail Psoriasis and DIP Enthesitis: The chi‑square test demonstrated a strong association (χ² = 8.71, p = 0.003). After adjusting for age, sex, disease duration, and PsA status, multivariate logistic regression yielded an adjusted odds ratio of 3.52 (95 % CI 1.28‑9.67; p = 0.014). This indicates that patients with nail psoriasis are over three times more likely to have DIP enthesitis than those without nail changes, independent of other variables. Sub‑Analysis by PsA Status: Among participants with PsA, 70 % (n = 25) had nail psoriasis, and 55 % (n = 20) exhibited DIP enthesitis. In the non‑PsA subgroup, 58 % (n = 35) showed nail involvement, but only 22 % (n = 13) had enthesitis, reinforcing the synergistic effect of joint disease and nail pathology. Clinical Correlation: Patients with both nail psoriasis and DIP enthesitis reported higher mean visual analogue scale (VAS) scores for finger pain (6.2 ± 1.4) versus those with nail disease alone (3.8 ± 1.1) or enthesitis alone (4.1 ± 1.2). These data collectively support a robust link between nail pathology and subclinical DIP enthesitis, emphasizing the need for integrated dermatological and rheumatological assessment. Clinical Implications Screening Recommendations: Clinicians should perform a thorough nail examination in every patient with psoriasis, regardless of joint symptoms. The presence of nail pitting, onycholysis, or subungual hyperkeratosis warrants a focused inquiry about finger pain, stiffness, or swelling. When nail disease is identified, referral for musculoskeletal ultrasound—or, where unavailable, a detailed clinical enthesitis exam—can uncover early DIP involvement. Treatment Considerations: Evidence suggests that biologic agents targeting IL‑17 or IL‑23 not only improve skin and joint disease but also reduce enthesitis activity. For patients with concurrent nail psoriasis and DIP enthesitis, early initiation of such agents may provide superior disease control compared with conventional disease‑modifying antirheumatic drugs (DMARDs) alone. Moreover, local corticosteroid injections into the affected enthesis may offer symptom relief in select cases. Prognostic Value: Nail psoriasis has emerged as a prognostic marker for PsA development. The added finding that nail disease predicts DIP enthesitis strengthens its role as an early warning sign. Patients with nail involvement should be counseled about the possibility of joint disease progression and encouraged to report new musculoskeletal symptoms promptly. Patient Education & Self‑Management: Education about proper nail care (e.g., avoiding trauma, using moisturizers, and gentle trimming) may alleviate nail inflammation and indirectly reduce mechanical stress on the underlying enthesis. Physical therapy focusing on finger range‑of‑motion exercises can maintain joint flexibility and reduce enthesopathic strain. Research Directions: Longitudinal studies are needed to determine whether treatment of nail psoriasis alone can reverse DIP enthesitis or prevent its onset. Additionally, larger multicenter trials employing standardized ultrasound scoring systems could validate the diagnostic algorithm proposed by this Karachi cohort. Frequently Asked Questions Q: Is nail psoriasis just a cosmetic problem? A: No. Nail psoriasis reflects inflammation of the nail matrix and bed, structures closely linked to the distal interphalangeal joint. It often predicts underlying joint disease, especially enthesitis, and should be evaluated by a dermatologist and rheumatologist. Q: What symptoms might indicate DIP joint enthesitis? A: Patients may report aching or tenderness at the base of the fingernail, swelling, reduced finger mobility, or a sensation of stiffness that worsens with activity. Ultrasound can detect enthesitis even before pain becomes evident. Q: Can ultrasound replace a physical exam for detecting enthesitis? A: Ultrasound is more sensitive than palpation alone and can visualize subtle changes such as hypoechoic thickening and Doppler signal. However, it complements—not replaces—clinical assessment. Both should be used together for optimal detection. Q: Which treatments are most effective for both nail psoriasis and enthesitis? A: Biologic agents that inhibit IL‑17 (e.g., secukinumab) or IL‑23 (e.g., guselkumab) have demonstrated efficacy in improving nail lesions and reducing enthesitis activity. Conventional DMARDs like methotrexate may help, but biologics generally provide faster and more comprehensive control. Q: Should all patients with psoriasis get screened for enthesitis? A: While universal screening may not be practical, patients with nail psoriasis, a family history of PsA, or persistent finger discomfort should be prioritized for enthesitis evaluation, ideally with ultrasound if available. By integrating nail assessment, imaging, and targeted therapy, healthcare providers can intervene earlier, reducing the burden of psoriatic disease on patients' daily lives. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Canine Femoral Trochlear Dysplasia and Dejour Signs: Clinical Relevance of Radiographs and Computed Tomography

Overview Recent research has shown that the radiographic patterns first described in human knee dysplasia—known as Dejour signs—can also be identified in dogs with patellar luxation (PL). The study titled “Canine Femoral Trochlear Dysplasia: A Retrospective Study Assessing the Dejour Signs” evaluated whether these classic imaging markers are present in healthy dogs versus dogs that suffer from PL, and whether modern computed tomography (CT) can replace traditional mediolateral radiographs for diagnosis (Source: PubMed / Europe PMC). Understanding these findings helps veterinarians and pet owners make more informed decisions about surgical planning and postoperative expectations. Patellar luxation is a common orthopedic problem in small‑breed dogs, often resulting in pain, lameness, and reduced quality of life. Accurate identification of femoral trochlear dysplasia influences the choice of surgical technique—whether to deepen the groove, realign the extensor mechanism, or perform a tibial plateau leveling osteotomy. By confirming that Dejour signs are both present and reliably visualized on CT, the study offers clinicians a modern, three‑dimensional tool that may improve pre‑operative planning and ultimately lead to better outcomes for dogs and their families. Medical Background Femoral trochlear dysplasia refers to an abnormal shape of the femoral trochlea—the cradle‑like groove at the end of the femur that guides the patella (kneecap) during movement. When the groove is too shallow, flat, or even convex, the patella can slip out of place, a condition called patellar luxation (PL). In dogs, PL is most often seen in toy and small breeds such as Maltese, Pomeranians, and Miniature Pinschers. The Dejour classification—originally created for human patients—identifies three radiographic landmarks that signal trochlear dysplasia: Crossing sign: the trochlear sulcus line crosses the distal femoral condyle, indicating a reduced trochlear depth. Supratrochlear spur: a bony prominence above the trochlear groove. Double‑contour sign: a duplicated outline of the trochlear articular surface, reflecting a flattened or dysplastic groove. These signs help surgeons decide whether a simple realignment is sufficient or whether a trochleoplasty (groove‑deepening) is required. The newly described “dome sign” reflects a convex trochlear surface on a single projection line and may correlate with more severe (grade‑4) PL. How the Procedure Works Standard diagnostic work‑up for a dog suspected of PL includes a physical examination, measurement of the quadriceps angle, and imaging of the stifle joint. Traditionally, a mediolateral radiograph is taken with the knee flexed to 30‑40° to best display the trochlear groove. The advent of CT scanners has allowed clinicians to reconstruct a true lateral view from volumetric data, eliminating superimposition of other bony structures and providing a clearer view of the trochlear morphology. Study Methodology The investigation was a retrospective case‑control study conducted at a single veterinary teaching hospital between 2015 and 2022. The authors screened hospital records for dogs that had undergone both mediolateral stifle radiographs and a CT scan of the same joint for any reason (e.g., pre‑operative planning, trauma assessment). Inclusion criteria were: Age between 6 months and 8 years. Availability of high‑quality mediolateral radiographs taken with the stifle flexed to 30°–40°. A CT study that included the distal femur and proximal tibia with slice thickness ≤1 mm. Clear documentation of patellar status (either normal or luxated) confirmed by orthopaedic examination. Forty femoral trochleae met these criteria and were divided into two groups: Control group: 15 dogs without any evidence of patellar instability (n = 15 trochleae). PL group: 25 dogs diagnosed with unilateral or bilateral patellar luxation (n = 25 trochleae). Within this group, luxation severity was graded according to the established 4‑grade system, where grade 4 represents the most severe and chronic displacement. All imaging studies were anonymized and randomised. A single board‑certified radiologist, blinded to the clinical status of each specimen, reviewed each image set for the presence of the three classic Dejour signs (crossing, supratrochlear spur, double‑contour) and for the newly proposed dome sign. The radiologist recorded each sign as present or absent, resulting in a binary outcome for each feature. Statistical analysis employed Cohen’s kappa (κ) to assess inter‑modality agreement (radiograph vs. CT) and McNemar’s test to examine differences in detection rates between the two imaging techniques. A p‑value  0.05), indicating that CT lateral reconstructions are interchangeable with conventional radiographs for identifying these dysplastic features. Importantly, the dome sign was consistently identified on both radiographs and CT in the same 24 % of PL cases, predominantly in dogs classified as grade‑4 luxation (5 out of 6 dome‑sign positive knees). This suggests a possible correlation between severe patellar displacement and a convex trochlear morphology. Clinical Implications These findings have several practical ramifications for veterinarians, orthopedic surgeons, and pet owners: Diagnostic confidence: The presence of any Dejour sign should raise suspicion for underlying femoral trochlear dysplasia, prompting a more thorough pre‑operative work‑up. Because the signs are rare in normal dogs, false‑positive rates are low. Imaging choice: CT offers a three‑dimensional assessment without the superimposition inherent to plain radiographs, yet the study demonstrates that CT lateral reconstructions detect Dejour signs with comparable accuracy. Consequently, clinicians can select the modality that best fits their practice logistics and the patient’s anesthesia status. Surgical planning: When one or more Dejour signs are present, especially in combination, surgeons may consider a trochleoplasty in addition to tibial tuberosity advancement or tibial plateau leveling osteotomy. The identification of a dome sign may further signal the need for groove deepening because a convex trochlea provides minimal bony restraint for the patella. Prognostic value: The association between the dome sign and grade‑4 PL suggests that dogs with this radiographic marker could have a more guarded postoperative outcome, necessitating closer follow‑up and potentially a more aggressive rehabilitation protocol. Owner communication: Veterinarians can use the visual evidence of Dejour signs to explain the anatomical basis of the disease to pet owners, fostering realistic expectations regarding surgery, recovery time, and the possibility of recurrence. In summary, recognizing Dejour signs and the dome sign on either radiographs or CT provides a reliable, objective method for assessing femoral trochlear dysplasia in dogs with PL. This enhances the surgeon’s ability to tailor the operative technique to the individual anatomy, which may reduce the incidence of postoperative luxation recurrence and improve long‑term limb function. Frequently Asked Questions Q: What are Dejour signs and why do they matter in dogs? A: Dejour signs are three specific radiographic markers—crossing sign, supratrochlear spur, and double‑contour sign—that indicate an abnormal shape of the femoral trochlea. Their presence suggests trochlear dysplasia, a key factor in patellar luxation, and helps the surgeon decide whether additional procedures like trochleoplasty are needed. Q: Can a plain radiograph miss a Dejour sign that a CT would detect? A: In this study, detection rates were statistically equivalent between the two modalities. However, CT eliminates overlap of adjacent bones and can provide a clearer view in cases where positioning is suboptimal, so it may be preferred in borderline or complex cases. Q: What is the “dome sign” and how should it influence treatment? A: The dome sign is a single‑line projection indicating a convex trochlear surface. It was observed in 24 % of PL‑affected knees, most often in grade‑4 luxations. Its presence may signal a more severe dysplasia, prompting the surgeon to consider a deeper trochlear groove correction. Q: Should every dog with patellar luxation undergo CT scanning? A: Routine CT is not mandatory, but it is advisable when the radiographs are inconclusive, when the dog is already under general anesthesia for another procedure, or when detailed three‑dimensional planning is required (e.g., combined tibial plateau leveling osteotomy and trochleoplasty). Q: Does the presence of Dejour signs predict a higher chance of surgical failure? A: While the study did not follow postoperative outcomes, other literature suggests that unaddressed trochlear dysplasia can lead to recurrence of luxation. Identifying Dejour signs pre‑operatively allows the surgeon to modify the technique, which is thought to reduce failure rates. For veterinarians and pet owners alike, the integration of Dejour sign assessment into standard diagnostic protocols represents a step forward in the evidence‑based management of patellar luxation—a condition that, when properly addressed, can return a dog to pain‑free activity and an improved quality of life. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Femoral Defect Repair

OverviewThe management of infected segmental defects of the femoral diaphysis is a challenging condition that affects many individuals, particularly those who have suffered from traumatic injuries or osteomyelitis. The induced membrane technique, also known as the Masquelet technique, is a promising 2-stage reconstructive method for large post-infectious bone defects. This technique has been shown to be effective in restoring stability and promoting bone regeneration in patients with significant femoral defects. In a recent case report, an 11-cm femoral diaphyseal defect secondary to chronic osteomyelitis was successfully repaired using the induced membrane technique in a 14-year-old girl (Source: PubMed).What This Study ExaminedThis study examined the use of the induced membrane technique for the reconstruction of a large post-infectious femoral diaphyseal defect. The technique involves a 2-stage procedure, where the first stage involves the removal of the infected bone segment and the placement of a vancomycin-loaded polymethylmethacrylate cement spacer around a locked intramedullary nail. The second stage involves the removal of the spacer and the placement of an autologous bone graft using a reamer-irrigator-aspirator system combined with iliac cancellous bone.Why This Matters for PatientsThe induced membrane technique offers a promising solution for patients with large post-infectious bone defects. This technique allows for the reconstruction of the bone defect while minimizing the risk of infection and promoting bone regeneration. The use of a vancomycin-loaded polymethylmethacrylate cement spacer and an autologous bone graft helps to ensure that the bone defect is properly filled and that the surrounding bone is healthy enough to support the graft.Medical BackgroundThe induced membrane technique is a reconstructive method used to repair large bone defects. This technique involves the creation of a membrane around the bone defect, which helps to promote bone growth and regeneration. The technique is typically used in conjunction with other methods, such as external fixation and intramedullary nailing. The use of autologous bone graft and reamer-irrigator-aspirator system helps to ensure that the bone defect is properly filled and that the surrounding bone is healthy enough to support the graft.How the Procedure WorksThe induced membrane technique involves a 2-stage procedure. The first stage involves the removal of the infected bone segment and the placement of a vancomycin-loaded polymethylmethacrylate cement spacer around a locked intramedullary nail. The second stage involves the removal of the spacer and the placement of an autologous bone graft using a reamer-irrigator-aspirator system combined with iliac cancellous bone.Who Is a Candidate?The induced membrane technique is typically used to treat patients with large post-infectious bone defects. This technique is particularly useful for patients who have suffered from traumatic injuries or osteomyelitis. The technique is also useful for patients who have failed to respond to other treatments, such as autologous bone graft alone.Clinical SummaryProcedure: The induced membrane technique is a 2-stage reconstructive method used to repair large post-infectious bone defects.Typical Duration: The procedure typically takes several months to complete, with the first stage involving the removal of the infected bone segment and the placement of a vancomycin-loaded polymethylmethacrylate cement spacer around a locked intramedullary nail.Recovery: The recovery time for the induced membrane technique varies depending on the individual patient and the extent of the bone defect.Success Rate (general): The success rate of the induced membrane technique is generally high, with most patients achieving significant improvement in their symptoms and functional ability.Study MethodologyThe study involved a 14-year-old girl who sustained a Gustilo-Anderson type II open fracture of the right femoral shaft after a motor vehicle accident. The patient underwent debridement and external fixation, but developed pin-site infection and infected nonunion with chronic osteomyelitis 6 months after injury. The patient was treated with the induced membrane technique, which involved a 2-stage procedure.Patient Selection CriteriaThe patient was selected for the study based on the presence of a large post-infectious femoral diaphyseal defect. The patient had failed to respond to other treatments, including autologous bone graft alone.Outcome MeasuresThe outcome measures used in the study included radiographic bone healing, functional ability, and the presence of recurrent infection.Results & FindingsThe study found that the induced membrane technique was effective in repairing the large post-infectious femoral diaphyseal defect. The patient achieved significant improvement in their symptoms and functional ability, and radiographic bone healing was observed at 6 months after the second-stage procedure.Key OutcomesThe key outcomes of the study included the successful reconstruction of the femoral diaphyseal defect, the achievement of radiographic bone healing, and the absence of recurrent infection.Complications & RisksThe study identified several complications and risks associated with the induced membrane technique, including the risk of recurrent infection, neurological damage, and thromboembolic events.Key Takeaways for PatientsThe induced membrane technique is a promising solution for patients with large post-infectious bone defects.The technique involves a 2-stage procedure, with the first stage involving the removal of the infected bone segment and the placement of a vancomycin-loaded polymethylmethacrylate cement spacer around a locked intramedullary nail.The second stage involves the removal of the spacer and the placement of an autologous bone graft using a reamer-irrigator-aspirator system combined with iliac cancellous bone.Patient should ask their surgeon about the potential risks and benefits of the induced membrane technique, as well as the expected outcomes and recovery time.Frequently Asked QuestionsWhat is the induced membrane technique?The induced membrane technique is a reconstructive method used to repair large bone defects. It involves the creation of a membrane around the bone defect, which helps to promote bone growth and regeneration.How long does the procedure take?The procedure typically takes several months to complete, with the first stage involving the removal of the infected bone segment and the placement of a vancomycin-loaded polymethylmethacrylate cement spacer around a locked intramedullary nail.What are the potential risks and complications of the induced membrane technique?The potential risks and complications of the induced membrane technique include the risk of recurrent infection, neurological damage, and thromboembolic events.What is the success rate of the induced membrane technique?The success rate of the induced membrane technique is generally high, with most patients achieving significant improvement in their symptoms and functional ability.How long is the recovery time for the induced membrane technique?The recovery time for the induced membrane technique varies depending on the individual patient and the extent of the bone defect. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →